A Tale of Two Fractals: The Hofstadter Butterfly and The Integral Apollonian Gaskets

This paper unveils a mapping between a quantum fractal that describes a physical phenomena, and an abstract geometrical fractal. The quantum fractal is the Hofstadter butterfly discovered in 1976 in an iconic condensed matter problem of electrons moving in a two-dimensional lattice in a transverse magnetic field. The geometric fractal is the integer Apollonian gasket characterized in terms of a 300 BC problem of mutually tangent circles. Both of these fractals are made up of integers. In the Hofstadter butterfly, these integers encode the topological quantum numbers of quantum Hall conductivity. In the Apollonian gaskets an infinite number of mutually tangent circles are nested inside each other, where each circle has integer curvature. The mapping between these two fractals reveals a hidden threefold symmetry embedded in the kaleidoscopic images that describe the asymptotic scaling properties of the butterfly. This paper also serves as a mini review of these fractals, emphasizing their hierarchical aspects in terms of Farey fractions

Manifestation of triplet superconductivity in superconductor-ferromagnet structures

We study proximity effects in a multilayered superconductor/ferromagnet (S/F) structure with arbitrary relative directions of the magnetization ${\bf M}$. If the magnetizations of different layers are collinear the superconducting condensate function induced in the F layers has only a singlet component and a triplet one with a zero projection of the total magnetic moment of the Cooper pairs on the ${\bf M}$ direction. In this case the condensate penetrates the F layers over a short length $\xi_J$ determined by the exchange energy $J$. If the magnetizations ${\bf M}$ are not collinear the triplet component has, in addition to the zero projection, the projections $\pm1$. The latter component is even in the momentum, odd in the Matsubara frequency and penetrates the F layers over a long distance that increases with decreasing temperature and does not depend on $J$ (spin-orbit interaction limits this length). If the thickness of the F layers is much larger than $\xi_J$, the Josephson coupling between neighboring S layers is provided only by the triplet component, so that a new type of superconductivity arises in the transverse direction of the structure. The Josephson critical current is positive (negative) for the case of a positive (negative) chirality of the vector ${\bf M}$. We demonstrate that this type of the triplet condensate can be detected also by measuring the density of states in F/S/F structures.Comment: 14 pages; 9 figures. Final version, to be published in Phys. Rev.

An official American thoracic society workshop report: Translational research in rare respiratory diseases

Rare respiratory diseases (RRDs) are a heterogeneous group of disorders that collectively represent a significant health care burden. In recent years, strong advocacy and policy initiatives have led to advances in the implementation of research and clinical care for rare diseases. The development of specialized centers and research networks has facilitated support for affected individuals as well as emerging programs in basic, translational, and clinical research. In selected RRDs, subsequent gains in knowledge have informed the development of targeted therapies and effective diagnostic tests, but many gaps persist. There was therefore a desire to identify the elements contributing to an effective translational research program in RRDs. To this end, a workshop was convened in October 2015 with a focus on the implementation of effective transnational research networks and collaborations aimed at developing novel diagnostic and therapeutic tools. Key elements included an emphasis on molecular pathogenesis, the continuing engagement of patient advocacy groups and policy makers, the effective use of preclinical models in the translational research pipeline, and the detailed phenotyping of patient cohorts. During the course of the workshop, current logistical and knowledge gapswere identified, and new solutions or opportunities were highlighted

Designing a broad-spectrum integrative approach for cancer prevention and treatment

Targeted therapies and the consequent adoption of "personalized" oncology have achieved notablesuccesses in some cancers; however, significant problems remain with this approach. Many targetedtherapies are highly toxic, costs are extremely high, and most patients experience relapse after a fewdisease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistantimmortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are notreliant upon the same mechanisms as those which have been targeted). To address these limitations, aninternational task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspectsof relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a widerange of high-priority targets (74 in total) that could be modified to improve patient outcomes. For thesetargets, corresponding low-toxicity therapeutic approaches were then suggested, many of which werephytochemicals. Proposed actions on each target and all of the approaches were further reviewed forknown effects on other hallmark areas and the tumor microenvironment. Potential contrary or procar-cinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixedevidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of therelationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. Thisnovel approach has potential to be relatively inexpensive, it should help us address stages and types ofcancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for futureresearch is offered

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Do instream habitat variables and the abundance of brown trout Salmo trutta (L.) affect the distribution and growth of stone loach, Barbatula barbatula (L.)?

Along a stream, we investigated whether the abundance of stone loach (Barbatula barbatula, L.) was related to the presence of brown trout (Salmo trutta, L.) and instream habitat variables. First, a field survey was carried out where different habitat variables and the densities of both species were quantified and subjected to principal components analysis. Then the abundance of stone loach was related to the scores of the retained axes (eigenvalues >1). The abundance of stone loach was positively correlated to substrate particle size, amount of shade, temperature, discharge and current velocity, but negatively correlated to brown trout abundance. Secondly, a month-long field enclosure experiment in a stream was performed to test for any negative effects of brown trout on stone loach growth. Four treatments were used: intraspecific competition (stone loach at double density), interspecific competition (stone loach + small trout), predation (stone loach + large trout) and a control (stone loach alone). The results showed that large trout tended to have negative effects on final stone loach biomass. The absence of a negative effect of large trout on resource density suggests that nonlethal effects rather than resource competition caused this trend